W. Stephen Faraci
Pfizer (United States)(US)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Amino Acid Enzymes and Metabolism, Antibiotics Pharmacokinetics and Efficacy, Peptidase Inhibition and Analysis, Biochemical and Molecular Research
Most-Cited Works
- → Phosphodiesterases in the CNS: targets for drug development(2006)385 cited
- → Subcloning, expression, and purification of the enterobactin biosynthetic enzyme 2,3-dihydroxybenzoate-AMP ligase: demonstration of enzyme-bound (2,3-dihydroxybenzoyl)adenylate product(1989)130 cited
- → Synthesis and Oral Efficacy of a 4-(Butylethylamino)pyrrolo[2,3-d]pyrimidine: A Centrally Active Corticotropin-Releasing Factor1 Receptor Antagonist(1997)113 cited
- → Posttranslational amino acid epimerization: enzyme-catalyzed isomerization of amino acid residues in peptide chains.(1996)90 cited
- → Mechanism of inhibition of the PC1 .beta.-lactamase of Staphylococcus aureus by cephalosporins: importance of the 3'-leaving group(1985)77 cited
- → Mechanism of inactivation of alanine racemase by .beta.,.beta.,.beta.-trifluoroalanine(1989)68 cited
- → Elimination of a good leaving group from the 3'-position of a cephalosporin need not be concerted with .beta.-lactam ring opening: TEM-2 .beta.-lactamase-catalyzed hydrolysis of pyridine-2-azo-4'-(N',N'-dimethylaniline) cephalosporin (PADAC) and of cephaloridine(1984)65 cited
- → 2‐Amino‐4‐methylpyridine as a potent inhibitor of inducible NO synthase activity in vitro and in vivo(1996)64 cited
- → Slow tight-binding inhibition of prolyl endopeptidase by benzyloxycarbonyl-prolyl-prolinal(1990)60 cited
- → Racemization of alanine by the alanine racemases from Salmonella typhimurium and Bacillus stearothermophilus: energetic reaction profiles(1988)54 cited